Perfluoropropane human albumin microspheres (Nanfang Hospital)

全氟丙烷人血白蛋白微球(南方医院)

Report date: 2026/05/22 20:01:29

Base Information

Drug NamePerfluoropropane human albumin microspheres (Nanfang Hospital)
Drug Alias Name注射用全氟丙烷人血白蛋白微球
ClassificationDiagnostic agent (In vivo) > Contrast agentBiologics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsContrast agents
Global Approved IndicationsContrast agents
Approved Indications in ChinaContrast agents
Original Approved Country/TerritoryMainland China
Original Approved Date2019/04/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSouthern Hospital Of Southern Medical University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesXiamen Fuman Pharmaceutical Industry Co Ltd
Inactive CompaniesGuangdong Baiyi Pharmaceutical Co LtdSouthern Hospital Of Southern Medical University
Active IndicationsContrast agents
Inactive IndicationsN/A

Other Information

ATC CodeV08
Related LinksN/A